n yet heterogeneous disease has increased dramatically over the last 2 decades, with the potential to lead to meaningful clinical interventions for patients. We have now seen the first pharmacologic t...

k of longitudinal laboratory data. To address these limitations, we used granular longitudinal data from the Veterans Health Administration. Methods: This retrospective cohort study of Veterans Hea...